Retroperitoneal lymph node dissection (RPLND) has been an integral part of a multimodal treatment strategy in testicular cancer. Surgeons, over the last decade, have advanced the understanding of RPLND by adopting perioperative care pathways, innovative biomarkers, surgical techniques, and developing algorithms for managing complications. This review summarizes updates on various aspects including the enhanced recovery after surgery pathway, imaging techniques, surgical approaches, dissection templates, and the management of complications. We conclude that RPLND has undergone significant evolution and refinement in the modern era and will continue to hold a critical role in the care of patients with testicular cancer.
Keyphrases
- papillary thyroid
- quality improvement
- robot assisted
- healthcare
- palliative care
- lymph node
- patients undergoing
- rectal cancer
- squamous cell
- cardiac surgery
- pain management
- risk factors
- sentinel lymph node
- radical prostatectomy
- prostate cancer
- germ cell
- early stage
- squamous cell carcinoma
- acute kidney injury
- childhood cancer
- minimally invasive
- thoracic surgery
- smoking cessation